CONTEXT: Erythema induratum of Bazin (EIB) is considered to be a tuberculid reaction and consists of recurrent painful nodules. The differential diagnosis includes diseases like nodular vasculitis, perniosis, polyarteritis nodosa and erythema nodosum. 
INTRODUCTION
Erythema induratum of Bazin (EIB), also known as Bazin disease, tuberculosum, tuberculosis cutis indurativa and nodose tuberculid, is a chronic, nodular eruption that usually occurs on the lower legs of young women. It has been correlated with manifestations of tuberculin hypersensitivity consisting of a type of tuberculid that occurs on the legs, whereas nodular vasculitis represents the non-tuberculous counterpart. The number of reports of EIB has been decreasing in most developed countries in accordance with the decreasing incidence of tuberculosis.
However, no previous case of EIB associated with adrenal insufficiency has been described. In this paper, we report the first case of a patient with EIB who developed adrenal insufficiency.
CASE REPORT
The patient was a 45-year-old Caucasian female who had a history of systemic arterial hypertension and diabetes mellitus that started 10 years earlier and was treated with neutral prot- Ten days after anti-tuberculosis therapy was introduced, she experienced asthenia, depressive mood and dizziness when standing up. She did not have any orthostatic hypotension. Sertraline treatment was started but she did not show any response until 300 mg/day was reached.
She was hospitalized on three occasions due to heart failure and hyponatremia (sodium: 125 mg/dl). During the last hospitalization, insulin administration was completely stopped since she was showing good glucose control. Six months later, she started to present facial hyperpigmentation, and a skin biopsy showed a nonspecific increase in melanin without other histopathological lesions. Because of the combination of hyponatremia, good glucose control, asthenia, low blood pressure and facial hyperpigmentation, a serum sample was obtained for cortisol measurement. This showed that the levels of this hormone were low, at 1.9 mcg/dl (normal level in the mornings:
5-25 mcg/dl), as were the levels of dehydroepiandrosterone, 1.7 ng/ml (normal: 2.5-6.5 ng/ml), and dehydroepiandrosterone-sulfate, 187 ng/ml (normal: 354-2560 ng/ml). A diagnosis of Addison's disease was made. The eosinophil count was 600 cells/mm 3 . Computed tomography showed bilateral enlargement of the adrenal glands, with preserved outlines.
Glucocorticoid replacement was then started and the patient had a good outcome. She recovered from the asthenia and fatigue, her blood pressure and serum sodium returned to normal levels, and insulin administration was also resumed. Anti-tuberculosis drug treatment was resumed and, after two months, the regimen was reduced to isoniazid and rifampicin. This regimen was continued until completion of nine months of treatment.
At the end of the treatment, the ulcerated lesions had all healed and the nodules had resolved with only severe hyperpigmentation remaining. Three months following cessation of therapy, no new lesions had occurred and the patient remained well.
DISCUSSION
In this paper, we reported the first case of a patient with EIB who received anti-tuberculosis drugs and developed adrenal insufficiency. A search for other case reports in the PubMed/ Medline, Embase, Cochrane and Lilacs databases did not find any articles, as shown in Table 1 .
In 1861, Bazin gave the name erythema induratum to a nodular eruption that occurred on the lower legs of young women EIB is more frequently observed in females, in proportions of 9:1. The peak age of occurrence ranges from 20 to 30 years, and this period is characterized by painful nodules on the dorsal face of the legs, with diameters ranging from one centimeter to five centimeters. In 30% of the cases, these nodules may undergo necrosis and ulceration. as in the present case.
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After treatment with tuberculostatic drugs had been started, the patient developed clinical manifestations suggestive of adrenal insufficiency. This was confirmed by lower serum cortisol in the early morning. Because the patient's cortisol level was lower than 3 mcg/dl, it was unnecessary to perform a cortrosyn stimulation test. 11 It is worth noting that the adrenal failure developed after the anti-tuberculosis therapy had been started. Development of adrenal crises in patients who receive rifampicin has been described in the medical literature. 12 Rifampicin increases hepatic steroid metabolism, which may lead to increased corticosteroid requirements in patients with adrenal insufficiency. 13 This may have been the precipitating factor for the adrenal crisis in this particular case, given that is likely that our patient had inadequate adrenal reserves because of tuberculosis.
Tuberculosis is an important cause of adrenal insufficiency around the world, particularly in Brazil. 14 We did not make measurements on antibodies to steroid 21-hydroxylase in order to rule out autoimmune adrenalitis, but the findings of bilaterally enlarged adrenal glands were suggestive of tuberculosis as the cause of adrenal failure.
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CONCLUSIONS
The present study reported the clinical case of a patient with EIB who, after tuberculosis treatment, evolved with adrenal insufficiency. We emphasize that tuberculosis is still the main etiological factor for Addison's disease, especially in underdeveloped countries.
